Genentech Avastin Clears FDA; Colorectal Cancer Drug Costs $4,400 A Month
Genentech is launching its oncologic Avastin at a wholesale acquisition cost of $2,200 per dose for the average colorectal cancer patient
Genentech is launching its oncologic Avastin at a wholesale acquisition cost of $2,200 per dose for the average colorectal cancer patient